Fundraising Fox
Diagnostic Biochips
Glen Burnie, US · Founded 2012 · Delaware corporation · 1 known investors
Find your way into Diagnostic Biochips
Sign up to see every warm intro you have to Diagnostic Biochips
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Diagnostic Biochips team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Diagnostic Biochips develops multichannel neural probes for extracellular recording in electrophysiology research, along with cloud-based software for spike sorting and analysis. It serves neuroscience researchers studying the brain at the neural network level.
Founders & leadership
Diagnostic Biochips was founded in 2012 by Brian Jamieson.
BJ
Brian JamiesonFounder & CEOBrian Jamieson is founder and CEO of Diagnostic Biochips, which develops multichannel neural probes for extracellular recording and cloud-based software for spike sorting in neuroscience research.
FW
Fan WuCTO & VP Product DevelopmentHe joined Diagnostic Biochips in 2016 and spent nearly a decade as vice president of product development before moving into the CTO role in 2025. He also worked as a process engineer at SB Microsystems and conducted graduate and postdoctoral research at the University of Michigan.
RS
Robert Seaton CollinsNamed on SEC filing
Investors · 1
TEDCOreportedColumbia
How we know: funding news · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$1.2M disclosed across 2 rounds · 2017–2021
▶$1.1MraisedMar 2021 · 17 investors · BiotechnologyRule 506(b)
▶$1.1MraisedMar 2021 · 17 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Walter W. Buckley, IIIDirector
- Robert E. Keith, Jr.Director
- Greg AldenExecutive Officer, Director
- Brian Glenn JamiesonExecutive Officer, Director
- Robert Seaton CollinsDirector
- Offering amount
- $1.5M
- Amount sold
- $1.1M
- First sale
- Feb 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 04, 06b
▶$75KraisedOct 2017 · 1 investors · BiotechnologyRule 506(b)
▶$75KraisedOct 2017 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Robert Seaton CollinsExecutive Officer, Director
- Brian Glenn JamiesonExecutive Officer, Director
- Offering amount
- $750K
- Amount sold
- $75K
- Minimum investment
- $10K
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware, 2012
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Related companies · 4
BioChip LabsBioChip Labs provides laboratory testing services for blood disorders, including sickle cell disease and thalassemia, using traditional and proprietary blood cell analysis methods. The company conducts comprehensive biomarker assays and works with clinicians and researchers.
Molecular DevicesMolecular Devices provides automated systems and services to support 3D cell biology research workflows, including cell culture automation, organoid expansion services, and imaging analysis tools for drug discovery and preclinical research.
RevvityRevvity develops and sells reagents, instruments, software, and services for life sciences research and clinical diagnostics, serving pharmaceutical, biotech, academic and government institutions across drug discovery, development, and disease diagnosis workflows.
Imec IntImec is an independent research and innovation center for nanoelectronics and digital technology, operating semiconductor pilot lines, cleanrooms, and labs used by industrial partners, startups, and universities. It conducts chip design and process R&D applied to fields such as health, automotive, agritech, and energy, working in an open innovation model with the global microchip value chain.
Companies working in the same space as Diagnostic Biochips.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2016 | $1.3M |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $886K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2015 | $772.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $636.5K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $385.9K |
| National Institutes of Health (NIH)National Institutes of Health | Phase I | 2013 | $266.6K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does Diagnostic Biochips do?
- Diagnostic Biochips develops multichannel neural probes for extracellular recording in electrophysiology research, along with cloud-based software for spike sorting and analysis. It serves neuroscience researchers studying the brain at the neural network level.
- Who founded Diagnostic Biochips?
- Diagnostic Biochips was founded by Brian Jamieson in 2012.
- Who are Diagnostic Biochips's investors?
- Diagnostic Biochips's investors include TEDCO.
- How much funding has Diagnostic Biochips raised?
- Diagnostic Biochips has disclosed $1.2M raised across 2 rounds.
- Where is Diagnostic Biochips headquartered?
- Diagnostic Biochips is headquartered in Glen Burnie, US.